Epidemiology and Clinical Characteristics of Non-Hodgkin Lymphoma in Mexico

被引:9
作者
Hernandez-Ruiz, Eleazar [1 ,2 ,5 ]
Alvarado-Ibarra, Martha [2 ]
Juan Lien-Chang, Lourdes Esthela [3 ]
Banda-Garcia, Luisa [4 ]
Luis Aquino-Salgado, Jorge [1 ]
Barragan-Ibanez, Gabriel [1 ]
Fabiola Ramirez-Romero, Eva [5 ]
Nolasco-Cancino, Cesar [6 ,7 ]
Herrera-Olivares, Wilfrido [8 ]
de Jesus Morales-Adrian, Javier [9 ]
Patricia Paredes-Lozano, Eugenia [10 ]
Eugenia Espitia-Rios, Maria [2 ]
Gonzalez Lopez-Elizalde, Maria de Monserrat [11 ]
Luis Lopez-Arroyo, Jose [12 ]
Enrique Trejo-Gomora, Jorge [13 ]
Antonio De la Pena-Celaya, Jose [2 ]
Luis Alvarez-Vera, Jose [2 ]
Luz Arana-Luna, Luara [2 ]
Martinez-Rios, Annel [14 ]
Resendiz-Olea, Rodrigo [14 ]
Jazmin Rodriguez-Velasquez, Lucero [1 ]
Zapata-Canto, Nidia [15 ]
Manuel Perez-Zuniga, Juan [2 ,14 ]
机构
[1] Hosp Reg Alta Especialidad Oaxaca, Serv Hematol, Oaxaca, Oaxaca, Mexico
[2] ISSSTE, Ctr Med Nacl 20 Noviembre, Serv Hematol, Mexico City, DF, Mexico
[3] Unidad Oncol & Serv Salud Estado Puebla, Serv Hematol, Puebla, Mexico
[4] Hosp Gen Zona 11 Xalapa, Serv Hematol, Xalapa, Veracruz, Mexico
[5] ISSSTE, Hosp Reg Presidente Juarez Oaxaca, Serv Hematol, Oaxaca, Oaxaca, Mexico
[6] Hosp Reg Doctor Juan Graham Casasus Villahermosa, Serv Hematol, Villahermosa, Tabasco, Mexico
[7] Hosp CERACOM, Serv Hematol, Villahermosa, Tabasco, Mexico
[8] ISSSTE, Serv Hematol, Hosp Reg Puebla, Puebla, Mexico
[9] ISSSTE, Serv Hematol, Hosp Reg Merida, Yucatan, Mexico
[10] Hosp Reg 1 Octubre ISSSTE, Serv Hematol, Mexico City, DF, Mexico
[11] Hosp H Queretaro, Serv Hematol, Queretaro, Mexico
[12] Hosp Gen B Ciudad Juarez, Serv Hematol, Cd Juarez, Chihuahua, Mexico
[13] Hosp San Angel Inn Univ, Serv Hematol, Mexico City, DF, Mexico
[14] Hosp Reg Ignacio Zaragoza ISSSTE, Serv Hematol, Mexico City, DF, Mexico
[15] Inst Nacl Cancerol, Mexico City, DF, Mexico
关键词
Non-Hodgkin lymphoma; Histological subtype; B-cell lymphomas; NK/T-cell lymphoma; Chemotherapy regimen; B-CELL LYMPHOMA; CLASSIFICATION; PATHOGENESIS; SURVIVAL;
D O I
10.14740/wjon1351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There is no epidemiological registry in Mexico. The information about the epidemiology in our country is obtained by these types of studies, such as multicentric studies. A lot of improvements in the survival in non-Hodgkin lymphoma patients had occurred in the last 20 years. The access to treatment in these types of pathology could change the prognostic factors in Mexican Mestizos patients. The primary objective of the study was to learn what the most frequent histological varieties of non-Hodgkin lymphoma in Mexico are. The secondary objectives included clinical characteristics, treatments used, treatment response, disease-free survival and overall survival. Methods: A retrospective, descriptive study of consecutive cases was carried out in 14 hospitals across 14 Mexican states with patients diagnosed with non-Hodgkin lymphoma using the World Health Organization (WHO) 2008 criteria. Inclusion criteria included: >= 18 years of age, male or female, any clinical stage at diagnosis, who had received any chemotherapy regimen, with a known outcome. Descriptive statistics was performed for all variables, and survival was assessed using Kaplan-Meier curves. Results: Totally, 609 patients were enrolled, of which 545 were B-cell lymphomas and 64 were T-cell lymphomas. Median ages were 61 and 50, respectively. B-cell lymphomas were more common in males with 52.1%, and 65.5% of T-cell lymphomas occurred in females. For B-cell lymphomas, the two most frequent histological subtypes were diffuse large B-cell lymphoma in 63.9%, followed by follicular lymphoma at 18%. Meanwhile, 50% of T-cell lymphomas were of the T/natural killer (NK) subtype, and 87.1% of the patients received a CHOP-like regimen. Radiotherapy was given to 31% of B-cell Lymphomas and 46.9% of T-cell lymphomas. Overall survival at 9 years was 84.6% for B-cell lymphomas, and 73.4% for T-cell lymphomas. Conclusions: Diffuse large B-cell lymphoma constitutes the most frequent subtype for B-cell lymphomas in Mexico. The most frequent T-cell lymphoma is the NK/T histological subtype.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 26 条
  • [11] MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
    Hu, Shimin
    Xu-Monette, Zijun Y.
    Tzankov, Alexander
    Green, Tina
    Wu, Lin
    Balasubramanyam, Aarthi
    Liu, Wei-min
    Visco, Carlo
    Li, Yong
    Miranda, Roberto N.
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    Zhao, Xiaoying
    van Krieken, J. Han
    Huang, Qin
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Zhou, Fan
    Slack, Graham W.
    Gascoyne, Randy D.
    Tu, Meifeng
    Variakojis, Daina
    Chen, Weina
    Go, Ronald S.
    Piris, Miguel A.
    Moller, Michael B.
    Medeiros, L. Jeffrey
    Young, Ken H.
    [J]. BLOOD, 2013, 121 (20) : 4021 - 4031
  • [12] Survival in non-Hodgkin's lymphoma by histology and family history
    Ji, Jianguang
    Forsti, Asta
    Sundquist, Jan
    Lenner, Per
    Hemminki, Kari
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1711 - 1716
  • [13] Limited Stage Aggressive Non-Hodgkin Lymphoma: What Is Optimal Therapy?
    Kumar, Abhijeet
    Sundararajan, Srinath
    Puvvada, Soham
    Persky, Daniel O.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (09)
  • [14] Pathogenesis of Non-Hodgkin's Lymphoma
    Nogai, Hendrik
    Doerken, Bernd
    Lenz, Georg
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) : 1803 - 1811
  • [15] Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project
    Perry, Anamarija M.
    Diebold, Jacques
    Nathwani, Bharat N.
    MacLennan, Kenneth A.
    Muller-Hermelink, Hans K.
    Bast, Martin
    Boilesen, Eugene
    Armitage, James O.
    Weisenburger, Dennis D.
    [J]. HAEMATOLOGICA, 2016, 101 (10) : 1244 - 1250
  • [16] Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
    Schmitz, Norbert
    Truemper, Lorenz
    Ziepert, Marita
    Nickelsen, Maike
    Ho, Anthony D.
    Metzner, Bernd
    Peter, Norma
    Loeffler, Markus
    Rosenwald, Andreas
    Pfreundschuh, Michael
    [J]. BLOOD, 2010, 116 (18) : 3418 - 3425
  • [17] The tumour microenvironment in B cell lymphomas
    Scott, David W.
    Gascoyne, Randy D.
    [J]. NATURE REVIEWS CANCER, 2014, 14 (08) : 517 - 534
  • [18] Non-Hodgkin lymphoma
    Shankland, Kate R.
    Armitage, James O.
    Hancock, Barry W.
    [J]. LANCET, 2012, 380 (9844) : 848 - 857
  • [19] A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
    SHIPP, MA
    HARRINGTON, DP
    ANDERSON, JR
    ARMITAGE, JO
    BONADONNA, G
    BRITTINGER, G
    CABANILLAS, F
    CANELLOS, GP
    COIFFIER, B
    CONNORS, JM
    COWAN, RA
    CROWTHER, D
    DAHLBERG, S
    ENGELHARD, M
    FISHER, RI
    GISSELBRECHT, C
    HORNING, SJ
    LEPAGE, E
    LISTER, TA
    MEERWALDT, JH
    MONTSERRAT, E
    NISSEN, NI
    OKEN, MM
    PETERSON, BA
    TONDINI, C
    VELASQUEZ, WA
    YEAP, BY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) : 987 - 994
  • [20] Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
    Smith, A.
    Crouch, S.
    Lax, S.
    Li, J.
    Painter, D.
    Howell, D.
    Patmore, R.
    Jack, A.
    Roman, E.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1575 - 1584